Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-18

Clinical Trial Update: Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of benzalkonium chloride-preserved vs preservative-free latanoprost eye drops on conjunctival goblet cells in glaucoma/ocula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: RECRUITING